 | • レポートコード：B-GIR09D4255 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レフサム病治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。レフサム病治療の世界市場概観、企業動向、企業別レフサム病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レフサム病治療の市場概観 ・レフサム病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レフサム病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・レフサム病治療の世界市場規模 ・レフサム病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・レフサム病治療のアメリカ市場規模推移 ・レフサム病治療のカナダ市場規模推移 ・レフサム病治療のメキシコ市場規模推移 ・レフサム病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レフサム病治療のドイツ市場規模推移 ・レフサム病治療のイギリス市場規模推移 ・レフサム病治療のロシア市場規模推移 ・レフサム病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レフサム病治療の日本市場規模推移 ・レフサム病治療の中国市場規模推移 ・レフサム病治療の韓国市場規模推移 ・レフサム病治療のインド市場規模推移 ・レフサム病治療の東南アジア市場規模推移 ・レフサム病治療の南米市場分析（ブラジル、アルゼンチン等） ・レフサム病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レフサム病治療の種類別分析/販売量、売上、市場シェア（手術療法、薬物療法） ・レフサム病治療の用途別分析/市場規模（病院、診療所、その他） ・レフサム病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レフサム病治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues.
Scope of the Report:
The Americas dominate the refsum disease market owing to the rising awareness among people and high healthcare expenditure.
The Asia Pacific is the fastest growing refsum disease market owing to a huge patient pool and developing healthcare technology.
The global Refsum Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Refsum Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Refsum Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Refsum Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Fresenius Kabi
B. Braun Melsungen
Cook
Medline Industries
Illumina
Cochlear Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgery Therapy
Medication
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Refsum Disease Treatment Market Overview
1.1 Product Overview and Scope of Refsum Disease Treatment
1.2 Classification of Refsum Disease Treatment by Types
1.2.1 Global Refsum Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Refsum Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Surgery Therapy
1.2.4 Medication
1.3 Global Refsum Disease Treatment Market by Application
1.3.1 Global Refsum Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Refsum Disease Treatment Market by Regions
1.4.1 Global Refsum Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Refsum Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Refsum Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Refsum Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Refsum Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Refsum Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Refsum Disease Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Fresenius Kabi
2.1.1 Business Overview
2.1.2 Refsum Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Fresenius Kabi Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 B. Braun Melsungen
2.2.1 Business Overview
2.2.2 Refsum Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 B. Braun Melsungen Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cook
2.3.1 Business Overview
2.3.2 Refsum Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cook Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Medline Industries
2.4.1 Business Overview
2.4.2 Refsum Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medline Industries Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Illumina
2.5.1 Business Overview
2.5.2 Refsum Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cochlear Limited
2.6.1 Business Overview
2.6.2 Refsum Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cochlear Limited Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Refsum Disease Treatment Market Competition, by Players
3.1 Global Refsum Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Refsum Disease Treatment Players Market Share
3.2.2 Top 10 Refsum Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Refsum Disease Treatment Market Size by Regions
4.1 Global Refsum Disease Treatment Revenue and Market Share by Regions
4.2 North America Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Refsum Disease Treatment Revenue by Countries
5.1 North America Refsum Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Refsum Disease Treatment Revenue by Countries
6.1 Europe Refsum Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Refsum Disease Treatment Revenue by Countries
7.1 Asia-Pacific Refsum Disease Treatment Revenue by Countries (2014-2019)
7.2 China Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Refsum Disease Treatment Revenue by Countries
8.1 South America Refsum Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Refsum Disease Treatment by Countries
9.1 Middle East and Africa Refsum Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Refsum Disease Treatment Market Segment by Type
10.1 Global Refsum Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Refsum Disease Treatment Market Forecast by Type (2019-2024)
10.3 Surgery Therapy Revenue Growth Rate (2014-2024)
10.4 Medication Revenue Growth Rate (2014-2024)
11 Global Refsum Disease Treatment Market Segment by Application
11.1 Global Refsum Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Refsum Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Refsum Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Refsum Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Refsum Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Refsum Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Refsum Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Refsum Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Refsum Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Refsum Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Refsum Disease Treatment Picture
Table Product Specifications of Refsum Disease Treatment
Table Global Refsum Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Refsum Disease Treatment Revenue Market Share by Types in 2018
Figure Surgery Therapy Picture
Figure Medication Picture
Table Global Refsum Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Refsum Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Refsum Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Refsum Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius Kabi Refsum Disease Treatment Type and Applications
Table Fresenius Kabi Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen Refsum Disease Treatment Type and Applications
Table B. Braun Melsungen Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cook Basic Information, Manufacturing Base and Competitors
Table Cook Refsum Disease Treatment Type and Applications
Table Cook Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Medline Industries Basic Information, Manufacturing Base and Competitors
Table Medline Industries Refsum Disease Treatment Type and Applications
Table Medline Industries Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Refsum Disease Treatment Type and Applications
Table Illumina Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cochlear Limited Basic Information, Manufacturing Base and Competitors
Table Cochlear Limited Refsum Disease Treatment Type and Applications
Table Cochlear Limited Refsum Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Refsum Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Refsum Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Refsum Disease Treatment Revenue Share by Players in 2017
Figure Global Refsum Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Refsum Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Refsum Disease Treatment Revenue Market Share in 2018
Figure Global Refsum Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Refsum Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Refsum Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Refsum Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Refsum Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Refsum Disease Treatment Revenue by Countries (2014-2019)
Table North America Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Refsum Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Refsum Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Refsum Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Refsum Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Refsum Disease Treatment Revenue Market Share by Countries in 2018
Figure China Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Refsum Disease Treatment Revenue by Countries (2014-2019)
Table South America Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Refsum Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Refsum Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Refsum Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Refsum Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Refsum Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Refsum Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Refsum Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Refsum Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Refsum Disease Treatment Revenue Share by Type in 2019
Table Global Refsum Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Refsum Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Surgery Therapy Revenue Growth Rate (2014-2019)
Figure Global Medication Revenue Growth Rate (2014-2019)
Table Global Refsum Disease Treatment Revenue by Application (2014-2019)
Table Global Refsum Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Refsum Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Refsum Disease Treatment Revenue Share by Application in 2019
Table Global Refsum Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Refsum Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Refsum Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Refsum Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Refsum Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Refsum Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Refsum Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Refsum Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Refsum Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Refsum Disease Treatment Revenue Market Forecast (2019-2024)
世界のアジソン病治療市場予測（～2024年） Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin…- 世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界のバッテン病治療市場予測（～2024年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Scope of the Report: The global Batten Disease Treatment market is valued at xx milli…
- 世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 世界の腎疾患治療市場予測（～2024年） Scope of the Report: The global Renal Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…